MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

301.79 +3.79 (+1.27%)
Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
News headline image
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
From Charles River Laboratories International, Inc.
Via Business Wire
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Monday? ↗
Via Chartmill
News headline image
Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan ↗
Charles River Laboratories International (NYSE:CRL) outlined a strategy to accelerate growth, expand margins and modernize its operations during its 2026 Investor Day, setting financial targets through... 
Via MarketBeat
Topics Artificial Intelligence
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Why Charles River Laboratories (CRL) Stock Is Up Today
What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 5.7% in the afternoon session after the company outlined long-term... 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Unpopular Stocks Walking a Fine Line
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Why Charles River Laboratories (CRL) Stock Is Trading Up Today
What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 3.6% in the afternoon session after the company announced the laun... 
Via StockStory
News headline image
Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Reasons to Sell CRL and 1 Stock to Buy Instead
What a fantastic six months it’s been for Charles River Laboratories. Shares of the company have skyrocketed 79.5%, hitting $272.74. This was partly thanks t... 
Via StockStory
News headline image
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Wall Street Is Now Backing the Clarity Act. Here's the Most Likely Scenario for What Happens Next With Crypto. ↗
Even if there's no clarity on the Clarity Act, Coinbase and Circle could still power higher over the next 12 months. 
Via The Motley Fool
Topics Government
News headline image
Here's How Much $100 Invested In Charles River 15 Years Ago Would Be Worth Today ↗
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.75% on an annualized basis producing an average annual return of 15.76%. Currently, Charles River has a market... 
Via Benzinga
News headline image
3 Inflated Stocks We Approach with Caution
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
Via StockStory
News headline image
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today ↗
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.07% on an annualized basis producing an average annual return of 15.79%. Currently, Charles River has a market... 
Via Benzinga
News headline image
1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript ↗
Organic revenue returned to growth as biopharmaceutical demand strengthened. 
Via The Motley Fool
Topics Earnings
News headline image
5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call
Charles River Laboratories’ second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management hi... 
Via StockStory
Topics Artificial Intelligence Earnings Economy
News headline image
Charles River Laboratories International Q2 Earnings Call Highlights ↗
Charles River Laboratories International (NYSE:CRL) reported second-quarter results that exceeded its prior outlook, citing improved demand in its Discovery and Safety Assessment, or DSA, business and... 
Via MarketBeat
Topics Earnings
News headline image
CRL Q2 Deep Dive: Strategic Portfolio Moves and Biopharma Demand Fuel Margin Expansion
Lab services company Charles River Laboratories (NYSE:CRL) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales fell by 2.7% year on ... 
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
Which S&P500 stocks are gapping on Wednesday? ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story